Ritter Daniher Financial Advisory’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-70
Closed -$502 611
2025
Q4
$502 Hold
70
﹤0.01% 579
2025
Q3
$748 Hold
70
﹤0.01% 443
2025
Q2
$678 Buy
+70
New +$722 ﹤0.01% 318
2024
Q4
Sell
-5,000
Closed -$95.7K 322
2024
Q3
$95.7K Hold
5,000
0.03% 116
2024
Q2
$104K Hold
5,000
0.03% 109
2024
Q1
$94K Hold
5,000
0.03% 114
2023
Q4
$72.1K Buy
+5,000
New +$68K 0.03% 125
2021
Q4
Sell
-5
Closed 246
2021
Q3
$0 Sell
5
-33
-87% -$1.06K ﹤0.01% 215
2021
Q2
$1K Buy
+38
New +$1.25K ﹤0.01% 199

Other funds holding OGN

Ritter Daniher Financial Advisory's OGN Position: Q1 2026 in Review

Ritter Daniher Financial Advisory sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 70 shares — an estimated $502 sold.

Ritter Daniher Financial Advisory first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $104K in Q2 2024. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Ritter Daniher Financial Advisory reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Ritter Daniher Financial Advisory sold 70 Organon & Co shares in Q1 2026, an estimated $502.
  • Ritter Daniher Financial Advisory first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Ritter Daniher Financial Advisory's Organon & Co position peaked at $104K in Q2 2024.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q1 2026, filed 6 May 2026.